Bone protein, particularly bone morphogenetic proteins (BMPs), is used in clinical settings to support and treat broken bones, with substantial scientific validation. BMPs are a group of growth factors known to play a crucial role in bone formation and healing. Recombinant human BMPs (such as BMP-2 and BMP-7) have been developed and are used in orthopedic and dental surgeries to stimulate bone growth, especially in cases where normal healing is compromised (e.g., non-union fractures, spinal fusion procedures).

Numerous peer-reviewed clinical studies and reviews support the efficacy of BMPs in promoting bone regeneration. For example, The New England Journal of Medicine (2002) published a landmark study demonstrating that BMP-2 was as effective as autogenous bone grafting in treating open tibial fractures. Systematic reviews and meta-analyses have also found that BMPs improve the rate of bone healing and reduce the need for secondary procedures compared to traditional approaches.

The use of bone protein is not based on tradition but on modern molecular biology and biotechnology. While there are some concerns about side effects and appropriate dosing, the overall scientific consensus supports the use of specific bone proteins in carefully selected clinical scenarios to enhance bone repair and healing.